Join our LIVE Webinar on Tuesday, May 23 on “Advances in DAA therapy & HCV reinfection in PWID”
Please join us on Tuesday, May 23rd at 4:30 PM EST for a presentation by Dr. Jason Grebely of the Kirby Institute at the UNSW Australia and the International Network on Hepatitis in Substance Users (INHSU). Dr. Grebely will present: "Advances in DAA therapy and HCV reinfection among people who inject drugs" About Dr. Grebely: Jason Grebely is an Associate Professor in the Viral Hepatitis Clinical Program at the Kirby Institute, UNSW Australia. Jason’s research focuses on the epidemiology and treatment of HCV, with a focus on people who inject drugs. He has published over 150 peer-reviewed publications and has current research funding from the Canadian CIHR, Australian NHMRC and the US NIH.
Click here to join!